These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29020979)

  • 1. Perfectly matched 20-nucleotide guide RNA sequences enable robust genome editing using high-fidelity SpCas9 nucleases.
    Zhang D; Zhang H; Li T; Chen K; Qiu JL; Gao C
    Genome Biol; 2017 Oct; 18(1):191. PubMed ID: 29020979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage.
    Kulcsár PI; Tálas A; Huszár K; Ligeti Z; Tóth E; Weinhardt N; Fodor E; Welker E
    Genome Biol; 2017 Oct; 18(1):190. PubMed ID: 28985763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
    Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
    Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationally engineered Cas9 nucleases with improved specificity.
    Slaymaker IM; Gao L; Zetsche B; Scott DA; Yan WX; Zhang F
    Science; 2016 Jan; 351(6268):84-8. PubMed ID: 26628643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High fidelity CRISPR/Cas9 increases precise monoallelic and biallelic editing events in primordial germ cells.
    Idoko-Akoh A; Taylor L; Sang HM; McGrew MJ
    Sci Rep; 2018 Oct; 8(1):15126. PubMed ID: 30310080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boosting activity of high-fidelity CRISPR/Cas9 variants using a tRNA
    He X; Wang Y; Yang F; Wang B; Xie H; Gu L; Zhao T; Liu X; Zhang D; Ren Q; Liu X; Liu Y; Gao C; Gu F
    J Biol Chem; 2019 Jun; 294(23):9308-9315. PubMed ID: 31010827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.
    Chen JS; Dagdas YS; Kleinstiver BP; Welch MM; Sousa AA; Harrington LB; Sternberg SH; Joung JK; Yildiz A; Doudna JA
    Nature; 2017 Oct; 550(7676):407-410. PubMed ID: 28931002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blackjack mutations improve the on-target activities of increased fidelity variants of SpCas9 with 5'G-extended sgRNAs.
    Kulcsár PI; Tálas A; Tóth E; Nyeste A; Ligeti Z; Welker Z; Welker E
    Nat Commun; 2020 Mar; 11(1):1223. PubMed ID: 32144253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SpCas9-HF1 enhances accuracy of cell cycle-dependent genome editing by increasing HDR efficiency, and by reducing off-target effects and indel rates.
    Matsumoto D; Matsugi E; Kishi K; Inoue Y; Nigorikawa K; Nomura W
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102124. PubMed ID: 38328481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells.
    Tóth E; Weinhardt N; Bencsura P; Huszár K; Kulcsár PI; Tálas A; Fodor E; Welker E
    Biol Direct; 2016 Sep; 11():46. PubMed ID: 27630115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA targeting specificity of RNA-guided Cas9 nucleases.
    Hsu PD; Scott DA; Weinstein JA; Ran FA; Konermann S; Agarwala V; Li Y; Fine EJ; Wu X; Shalem O; Cradick TJ; Marraffini LA; Bao G; Zhang F
    Nat Biotechnol; 2013 Sep; 31(9):827-32. PubMed ID: 23873081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 'new lease of life': FnCpf1 possesses DNA cleavage activity for genome editing in human cells.
    Tu M; Lin L; Cheng Y; He X; Sun H; Xie H; Fu J; Liu C; Li J; Chen D; Xi H; Xue D; Liu Q; Zhao J; Gao C; Song Z; Qu J; Gu F
    Nucleic Acids Res; 2017 Nov; 45(19):11295-11304. PubMed ID: 28977650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleting specific residues from the HNH linkers creates a CRISPR-SpCas9 variant with high fidelity and efficiency.
    Wang G; Wang C; Chu T; Wu X; Anderson CM; Huang D; Li J
    J Biotechnol; 2023 May; 368():42-52. PubMed ID: 37116617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
    Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
    Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
    Kleinstiver BP; Tsai SQ; Prew MS; Nguyen NT; Welch MM; Lopez JM; McCaw ZR; Aryee MJ; Joung JK
    Nat Biotechnol; 2016 Aug; 34(8):869-74. PubMed ID: 27347757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the natural diversity and in vitro evolution of Cas9 to expand the genome editing toolbox.
    Karvelis T; Gasiunas G; Siksnys V
    Curr Opin Microbiol; 2017 Jun; 37():88-94. PubMed ID: 28645099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
    Steinert J; Schiml S; Fauser F; Puchta H
    Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designed nucleases for targeted genome editing.
    Lee J; Chung JH; Kim HM; Kim DW; Kim H
    Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SuperFi-Cas9 exhibits remarkable fidelity but severely reduced activity yet works effectively with ABE8e.
    Kulcsár PI; Tálas A; Ligeti Z; Krausz SL; Welker E
    Nat Commun; 2022 Nov; 13(1):6858. PubMed ID: 36369279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.